Pharmaceutical Industry Information Portal

HomeNews

News

Russia develops testing system capable of detecting Omicron coronavirus variant

A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of the virus has been developed...

Blood plasma-based drug against COVID-19 successfully passes clinical trials

The COVID-globulin medicine against coronavirus based on convalescent blood plasma has successfully passed clinical trials and received a permanent certification by the Russian Health...

Russian Ministry of Health included injectable Areplivir® in the guidelines for the treatment of COVID-19

The Ministry of Health of the Russian Federation has included the injectable form of the direct-acting antiviral drug Areplivir® (favipiravir) in the updated, fourteenth, version...

New Russian vaccine Convacell can be registered before end of 1Q 2022

New Russian vaccine against the coronavirus, Convacell, can be registered before the end of the first quarter of 2022, head of the Federal Bio-Medical...

Walter Reed Army Institute of Research Continues Recruitment for COVID-19 Clinical Trial

The vaccine, called spike ferritin nanoparticle (SpFN), stands out in the COVID-19 vaccine landscape. Scientists developed a nanoparticle vaccine, based on a ferritin platform,...

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...
spot_img

Expert Articles

spot_img